AAb=autoantibody; ADA=American Diabetes Association; DKA=diabetic ketoacidosis; ISPAD=International Society for Pediatric and Adolescent Diabetes; OGTT=oral glucose tolerance test; T1D=type 1 diabetes.
References: 1. Sims EK, Carr ALJ, Oram RA, et al. 100 years of insulin: celebrating the past, present and future of diabetes therapy. Nat Med. 2021;27(7):1154-1164. 2. Thakkar S, Chopra A, Nagendra L, et al. Teplizumab in type 1 diabetes mellitus: an updated review. touchREV Endocrinol. 2023;19(2):22-30. 3. diaTribe Learn. FDA approves Tzield (teplizumab) to delay type 1 diabetes. Published November 17, 2022. Updated November 21, 2022. https://diatribe.org/diabetes-medications/fda-approves-tzield-teplizumab-delay-type-1-diabetes 4. Pham-Huy A, Top KA, Constantinescu C, et al. The use and impact of monoclonal antibody biologics during pregnancy. CMAJ. 2021;193(29):1129-1136. 5. American Diabetes Association Diabetes Dialogues. Insulin is now a biologic—what does that mean? Accessed April 15, 2024. https://diabetes.org/blog/insulin-now-biologic-what-does-mean 6. TZIELD Prescribing Information. Provention Bio, Inc; 2023. 7. Insel RA, Dunne JL, Atkinson MA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care. 2015;38(10):1964-1974. 8. American Diabetes Association Professional Practice Committee. Diagnosis and classification of diabetes: standards of care in diabetes—2024. Diabetes Care. 2024;47(Suppl 1): S20–S42. 9. Type 1 Diabetes TrialNet. Protocol TN-10. Version June 2014. Accessed May 5, 2023. https://cdn.clinicaltrials.gov/large-docs/61/NCT01030861/Prot_000.pdf 10. Edelman S. Early intervention by family physicians to delay type 1 diabetes. J Fam Pract. 2023:72(6 suppl):S19-S24.